Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1346675717
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2797 Ocean Pkwy Ste 1
Brooklyn, NY, 11235
Phone (718) 615-4001
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
601 services
Medicare patients, 2024
289
Average age 74
Drug cost, 2024
$1.0M
701 prescriptions
Company payments, 2025
$1,635
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Inna Zeltser was code 99213 (office e&m - established), 351 times for 229 patients. In total Inna Zeltser billed 601 services in 12 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 351 | 229 | $65.93 | $23K |
| 99203 Office E&M - New | Office | 75 | 75 | $80.87 | $6,065 |
| 99441 Telephone Services | Office | 50 | 45 | $43.68 | $2,184 |
| 91200 Standard X-ray | Office | 23 | 22 | $24.15 | $555 |
| 91065 Test - Miscellaneous | Office | 13 | 13 | $58.66 | $763 |
By year: 2022 $39K for 407 services; 2023 $40K for 461 services; 2024 $38K for 601 services.
Medicare prescription drug claims, 2024
In 2024, the drug Inna Zeltser prescribed most often to Medicare patients was Zenpep (Lipase/Protease/Amylase), with 200 prescriptions and refills. In total Inna Zeltser wrote 701 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zenpep Lipase/Protease/Amylase | 200 | 214 | 33 | $690K |
| Linzess Linaclotide | 111 | 111 | 30 | $57K |
| Trulance Plecanatide | 61 | 61 | 11 | $32K |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 48 | 48 | Under 11 | $58K |
| Ibsrela Tenapanor Hcl | 38 | 38 | Under 11 | $62K |
| Procto-Med Hc Hydrocortisone | 32 | 32 | 13 | $226 |
| Hydrocortisone Generic | 30 | 31 | 16 | $216 |
| Creon Lipase/Protease/Amylase | 27 | 29 | 13 | $64K |
| Diclofenac Sodium Generic | 24 | 24 | Under 11 | $19K |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 17 | 17 | Under 11 | $348 |
Brand drugs: 495 claims; generic drugs: 206 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Inna Zeltser $1,635 ($1,635 in general payments such as food, travel and fees) from 12 companies. The largest payer was Ardelyx, Inc. with $355.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 14 | $355 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 10 | $272 |
| Aimmune Therapeutics, Inc. | 6 | $252 |
| Janssen Biotech, Inc. JNJ | 8 | $213 |
| Madrigal Pharmaceuticals MDGL | 6 | $192 |
| Abbvie Inc. ABBV | 9 | $172 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $57.56 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $26.96 |
| Boston Scientific Corporation BSX | 1 | $26.12 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $23.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.